Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 420 Precursor Cell Lymphoblastic Leukemia-Lymphoma 126 Neoplasms, Plasma Cell 74 Recurrence 70 Lymphoma 57 Leukemia 54 Neoplasms 46 Immunoglobulin Light-chain Amyloidosis 38 Burkitt Lymphoma 37 Vomiting 36 Lymphoma, Mantle-Cell 32 Lymphoma, Large B-Cell, Diffuse 31 Nausea 29 Lymphoma, Non-Hodgkin 28 Breast Neoplasms 22 Waldenstrom Macroglobulinemia 21 Lymphoma, Follicular 21 Hodgkin Disease 21 Leukemia, Lymphocytic, Chronic, B-Cell 20 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17 Neoplasm Metastasis 17 Prostatic Neoplasms 16 Lymphoma, Extranodal NK-T-Cell 16 Amyloidosis 16 Leukemia, Myeloid, Acute 15 Smoldering Multiple Myeloma 14 Lymphoma, B-Cell, Marginal Zone 13 Lung Neoplasms 11 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, B-Cell 10

Interventions

Misoprostol 5 Uterine Myomectomy 4 Saline Solution 3 Hysterectomy 3 dienogest 2 carbetocin 2 Tranexamic Acid 2 Tourniquets 2 Lidocaine 2 Hysteroscopy 2 Ascorbic Acid 2 remimazolam 1 relugolix 1 ramosetron 1 Vasopressins 1 Uterine Artery Embolization 1 Triptorelin Pamoate 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Respiration, Artificial 1 Remifentanil 1 Propofol 1 Population Groups 1 Oxytocin 1 Observation 1 Nuclear Receptor Subfamily 4, Group A, Member 2 1 Morcellation 1 Methylergonovine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Myofibroma × Dexamethasone × Clear all

NCT02056717 2015-04-17

Use of Dexamethasone in Uterine Artery Embolization

Severance Hospital

Phase NA Completed

Myofibroma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡